14C-labelling of NNC 756, a new dopamine D1 antagonist

1993 ◽  
Vol 33 (8) ◽  
pp. 747-757 ◽  
Author(s):  
Christian Foged ◽  
Louis B. Hansen ◽  
Christer Halldin
1955 ◽  
Vol 9 ◽  
pp. 709-709 ◽  
Author(s):  
Sten Gatenbeck ◽  
Agnar P. Nygaard ◽  
Roger Bonnichsen ◽  
Artturi I. Virtanen
Keyword(s):  

1994 ◽  
Vol 64 (2) ◽  
pp. 145-154
Author(s):  
Pascale Mosoni ◽  
Jean Michel Besle ◽  
Marie Paule Maillot ◽  
Liliane Gorrichon
Keyword(s):  

1988 ◽  
Vol 252 (3) ◽  
pp. 851-856 ◽  
Author(s):  
R Wallin ◽  
M Seaton ◽  
L F Martin

Recent research has shown that rat surfactant apoproteins (26-38 kDa) are vitamin K-dependent [Rannels, Gallaher, Wallin & Rannels (1987) Proc. Natl. Acad. Sci. U.S.A. 84, 5952-5956]. We have investigated the effect of the vitamin K antagonist warfarin on this family of apoproteins in surfactant from dog lung. Our data suggest that warfarin does not interfere with synthesis and secretion of these proteins into dog lung surfactant. Abnormal surfactant apoproteins, produced in response to warfarin treatment of the dog, were also not found in lung surfactant. 4-Carboxyglutamic acid analysis of purified dog apoproteins also failed to detect the vitamin K-modification. When vitamin K-dependent 14C labelling of precursors of vitamin K-dependent proteins was carried out, fluorography of these precursors, when electrophoresed into SDS/polyacrylamide gels, revealed 14C-labelled proteins of apparent molecular mass 74, 46, 42, 34, 31 and 23 kDa. Antibodies produced against purified dog surfactant apoproteins recognized precursors of the surfactant apoproteins in lung microsomes but did not recognize any 14C-labelled carboxylase substrates. These precursors appeared on immunoblots with apparent molecular mass 29, 32, 33 and 50 kDa. Our data suggest that there are significant differences between this class of surfactant apoproteins in the rat and the dog.


RADIOISOTOPES ◽  
1982 ◽  
Vol 31 (2) ◽  
pp. 101-103 ◽  
Author(s):  
Akira YOSHITAKE ◽  
Hideyuki GOMI ◽  
Iwao NAKATSUKA

1990 ◽  
Vol 269 (2) ◽  
pp. 459-464 ◽  
Author(s):  
R Wallin ◽  
F Rossi ◽  
R Loeser ◽  
L L Key

An osteoblast-like human osteosarcoma cell line (U2-OS) has been shown to possess a vitamin K-dependent carboxylation system which is similar to the system in human HepG2 cells and in liver and lung from the rat. In an ‘in vitro’ system prepared from these cells, vitamin K1 was shown to overcome warfarin inhibition of gamma-carboxylation carried out by the vitamin K-dependent carboxylase. The data suggest that osteoblasts, the cells involved in synthesis of vitamin K-dependent proteins in bone, can use vitamin K1 as an antidote to warfarin poisoning if enough vitamin K1 can accumulate in the tissue. Five precursors of vitamin K-dependent proteins were identified in osteosarcoma and HepG2 cells respectively. In microsomes (microsomal fractions) from the osteosarcoma cells these precursors revealed apparent molecular masses of 85, 78, 56, 35 and 31 kDa. When osteosarcoma cells were cultured in the presence of warfarin, vitamin K-dependent 14C-labelling of the 78 kDa precursor was enhanced. Selective 14C-labelling of one precursor was also demonstrated in microsomes from HepG2 cells and from rat lung after warfarin treatment. In HepG2 cells this precursor was identified as the precursor of (clotting) Factor X. This unique 14C-labelling pattern of precursors of vitamin K-dependent proteins in microsomes from different cells and tissues reflects a new mechanism underlying the action of warfarin.


Sign in / Sign up

Export Citation Format

Share Document